Transforming Women’s Health with Multipurpose Prevention Technologies (MPTs)
What Drives Us?
Every day, millions of women around the world suffer from the devastating consequences of infertility, long-term health complications, and even death, all due to pregnancy-related complications and sexually transmitted infections (STIs), including HIV. Globally, rates of STIs are increasing including in the US where rates of STIs reached an all time high in 2021, and more than doubled between 2012 and 2022 among those over 55. Yet, the only product available to simultaneously protect against these multiple risks is the condom. Women need more options!
At CAMI Health, we are changing that narrative. As the leader of a groundbreaking initiative, we’re advancing the development of multipurpose prevention technologies (MPTs)—a revolutionary new class of products that combine simultaneous protection against an array of STIs and/or unintended pregnancies in single, easy-to-use solutions. By driving innovation in MPTs, we’re empowering women with more choices to safeguard their health and improve the well-being of their families and communities.
Our Bold Vision
We envision a world were all women can prevent STIs and plan their families to ensure health and wellbeing throughout their lifespan.
To drive the development and adoption of Multipurpose Prevention Technologies (MPTs) that empower women with innovative, effective, and accessible solutions to simultaneously prevent STIs and unintended pregnancies. By advancing research, fostering collaboration, and translating science into action, we ensure women have the knowledge, tools, and choices they need to protect their lifelong sexual and reproductive health—because prevention transforms lives
Pioneering Prevention
For over two decades, CAMI Health has led the collaborative efforts driving Multipurpose Prevention Technologies (MPTs) forward. In 2003, we built a global network dedicated to advancing contraception and infection prevention. By 2009, we formally launched the MPT field and established the Initiative for MPTs (IMPT), paving the way for the first MPT clinical trials.
Now, in 2025, over 20 MPTs are in development that provide different combinations of protection against STIs, including chlamydia, bacterial vaginosis, herpes simplex virus, HIV and gonorrhea and/or unintended pregnancies. They could be used as intravaginal rings, films, inserts, injectables, gels or vaginal tablets. While most MPTs are in early stages of development, the first MPT is under regulatory review—a pivotal milestone in women’s health.
Driving Progress: The Evolution of the MPT Field
The Road Ahead
Imagine products that can provide protection against multiple STIs and offer contraception, or provide STI protection and not contraception depending on the woman's needs. This is what we are working towards with MPTs!
With over 20 MPT candidates in development, we are on the brink of transforming how women protect themselves from HIV, other STIs, and unintended pregnancy. Through strategic partnerships, cutting-edge research, and persistent advocacy, we’re accelerating the path to market—ensuring the first MPTs reach women and paving the way for even more choices in the future.
Now, we need your support to take the next critical steps:
-
Establish a dedicated fund to advance the most promising MPT candidates.
-
Sustain the IMPT—the world’s first and only global network solely focused on advancing MPTs.
Be part of a global movement for women's health
Learn More
CAMI Health leads the Initiative for Multipurpose Prevention Technologies (IMPT), the global collaboration driving MPT research, policy, and advocacy. Explore the latest developments and join the movement to expand prevention options for women worldwide.